Admedus is a medical technologies company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.


Clinically superior solutions that last a lifetime


Admedus TAVR gaining momentum with new patent applications in the US
Admedus Limited (ASX:AHZ) today announced that it has submitted several new provisional IP applications in the US for further development
Read more.
Admedus TAVR project passes testing milestone
Admedus Limited (ASX:AHZ) today announced that its Transcatheter Aortic Valve Replacement (TAVR) device project passed a key developmental milestone. Read
Read more.